Regeneron Kickback Issue Likely To Follow Teva To 1st Circ.
By Brian Dowling ( October 18, 2023, 3:11 PM EDT) -- A federal judge overseeing a False Claims Act case against Regeneron Pharmaceuticals Inc. said Wednesday he's leaning toward granting a mid-case appeal for the First Circuit to settle a critical legal question that's led to circuit splits and a divergent ruling involving Teva Pharmaceuticals....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.